RECORD // Company

Creative Medical Technology Holdings, Inc.

Formerly: JOLLEY MARKETING INC

Built 2026-11-21T23:55:31Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (1 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

SEC EDGAR (1)
Matched by name only, not merged (1)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

3 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-06 · accession 0001477932-26-006758

ItemValuePeriodFormFiledAccessionReport
Revenue$03 months ended 2026-09-3010-Q2026-11-060001477932-26-0067582026-11-21 23:55 UTCReport an error
Net income (loss)$-2,670,0763 months ended 2026-09-3010-Q2026-11-060001477932-26-0067582026-11-21 23:55 UTCReport an error
Cash and cash equivalents$6,845,741at 2026-09-3010-Q2026-11-060001477932-26-0067582026-11-21 23:55 UTCReport an error

Negative as reported in the filing.

Not in this report's XBRL: Interest expense.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001187953
Ticker
CELZ
EIN
870622284
CUSIP
22529Y408
Record ID
sx:sec:0001187953

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

32 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-13SEC EDGAR company profile2026-11-21 23:55 UTCReport an error
SIC industry2836 Biological Products, (No Diagnostic Substances)2026-11-13SEC EDGAR company profile2026-11-21 23:55 UTCReport an error
State of incorporationNV2026-11-13SEC EDGAR company profile2026-11-21 23:55 UTCReport an error
Fiscal year end (MMDD)12312026-11-13SEC EDGAR company profile2026-11-21 23:55 UTCReport an error
Business address211 E. OSBORN RD., PHOENIX, AZ, 850122026-11-13SEC EDGAR company profile2026-11-21 23:55 UTCReport an error
ExchangesNasdaq2026-11-13SEC EDGAR company profile2026-11-21 23:55 UTCReport an error
Revenue (fiscal year ended 2025-12-31)$6,0002025-12-3110-K, XBRL Revenues2026-11-21 23:55 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$-5,995,0082025-12-3110-K, XBRL NetIncomeLoss2026-11-21 23:55 UTCReport an error
Total assets (at 2025-12-31)$7,809,5252025-12-3110-K, XBRL Assets2026-11-21 23:55 UTCReport an error
Stockholders' equity (at 2025-12-31)$7,514,6452025-12-3110-K, XBRL StockholdersEquity2026-11-21 23:55 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$7,208,1262025-12-3110-K, XBRL CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents2026-11-21 23:55 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$-5,856,4452025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-21 23:55 UTCReport an error
Form D total offering amount (D filed 2022-05-05)$17,000,0012022-05-05D2026-11-21 23:55 UTCReport an error
Form D total amount sold (D filed 2022-05-05)$17,000,0012022-05-05D2026-11-21 23:55 UTCReport an error
Form D industry groupBiotechnology2022-05-05D2026-11-21 23:55 UTCReport an error
Form D revenue rangeDecline to Disclose2022-05-05D2026-11-21 23:55 UTCReport an error
Form D date of first sale2022-05-032022-05-05D2026-11-21 23:55 UTCReport an error
8-K Item 3.01, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (filed 2026-11-13)On November 10, 2026, Creative Medical Technology Holdings, Inc. (the “Company”) received a letter from The Nasdaq Stock Market stating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) because the closing bid price of the Company’s common stock was below $1.00 per share for 30 consecutive business days. The notice has no immediate impact on the Company’s listing. Pursuant to Nasdaq’s Listing Rules, the Company has a 180 day grace period, until May 10, 2027, during which the Company may regain compliance if the bid price of its common stock closes at $1.00 per share or more for a minimum of ten consecutive business days. The Company may be eligible for an additional…2026-11-13SEC EDGAR 8-K 0001477932-26-006933 (text as filed, excerpt)2026-11-21 23:55 UTCReport an error
8-K Item 1.01, Entry into a Material Definitive Agreement (filed 2026-09-25)On September 24, 2026, Creative Medical Technology Holdings, Inc. (the “Company”) entered into a Stock Purchase Agreement (the “Purchase Agreement”) with Creative Acquisition Corp. (“CAC”), pursuant to which the Company purchased 4,000,000 shares of common stock of BioDefense, Inc. (“BioDefense”) from CAC for an aggregate purchase price consisting of $200,000 in cash and 1,000,000 shares of the Company’s common stock. After giving effect to the transactions under the Purchase Agreement, the Company owns 16,000,000 shares of BioDefense common stock, constituting 80% of the outstanding shares of common stock of BioDefense, and CAC owns 4,000,000 shares of BioDefense common stock, constituting…2026-09-25SEC EDGAR 8-K 0001477932-26-005805 (text as filed, excerpt)2026-11-21 23:55 UTCReport an error
8-K Item 3.02, Unregistered Sales of Equity Securities (filed 2026-09-25)The disclosure in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.2026-09-25SEC EDGAR 8-K 0001477932-26-005805 (text as filed, excerpt)2026-11-21 23:55 UTCReport an error
8-K Item 5.03, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (filed 2026-08-31)On August 28, 2026, the stockholders of Creative Medical Technology Holdings, Inc. (the “Company”) approved an amendment to the Company’s Articles of Incorporation to increase the number of authorized shares of common stock from 25,000,000 to 100,000,000. The Company filed a Certificate of Amendment with the Secretary of State of the State of Nevada on August 28, 2026 to effect such increase. The Certificate of Amendment has been filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated by reference herein.2026-08-31SEC EDGAR 8-K 0001477932-26-005329 (text as filed, excerpt)2026-11-21 23:55 UTCReport an error
8-K Item 5.07, Submission of Matters to a Vote of Security Holders (filed 2026-08-31)On August 28, 2026, the Company held a Special Meeting of Stockholders (the “Special Meeting”) to consider and vote on proposals for (i) the approval of an amendment to the Company’s Articles of Incorporation increasing the number of the Company’s authorized shares of common stock from 25,000,000 shares to 100,000,000 shares (“Proposal I” or the “Share Increase Proposal”); and (ii) the approval of the exercise in full of warrants to purchase an aggregate of 5,580,680 shares of the Company’s common stock (the “Investor Warrants”) issued in a private placement on June 30, 2026 (“Proposal II”). Each of the foregoing proposals is described in more detail in the definitive proxy statement for…2026-08-31SEC EDGAR 8-K 0001477932-26-005329 (text as filed, excerpt)2026-11-21 23:55 UTCReport an error
Largest institutional holder #1 (13F as filed): Hudson Bay Capital Management LP$195,9972026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 23:55 UTCReport an error
Largest institutional holder #2 (13F as filed): Anson Funds Management LP$153,0462026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 23:55 UTCReport an error
Largest institutional holder #3 (13F as filed): ARMISTICE CAPITAL, LLC$60,9002026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 23:55 UTCReport an error
Largest institutional holder #4 (13F as filed): XTX Topco Ltd$38,5112026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 23:55 UTCReport an error
Largest institutional holder #5 (13F as filed): GEODE CAPITAL MANAGEMENT, LLC$37,4192026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 23:55 UTCReport an error
Largest institutional holder #6 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC$29,5082026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 23:55 UTCReport an error
Largest institutional holder #7 (13F as filed): VANGUARD FIDUCIARY TRUST CO$8,0012026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 23:55 UTCReport an error
Largest institutional holder #8 (13F as filed): Tower Research Capital LLC (TRC)$7,0372026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 23:55 UTCReport an error
Largest institutional holder #9 (13F as filed): Global Retirement Partners, LLC$5,9712026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 23:55 UTCReport an error
Largest institutional holder #10 (13F as filed): UBS Group AG$2,9892026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 23:55 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.